Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia
- 31 December 1994
- journal article
- Published by Elsevier in Genetic Analysis: Biomolecular Engineering
- Vol. 11 (4) , 90-94
- https://doi.org/10.1016/1050-3862(94)90045-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseBlood, 1993
- Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patientsBlood, 1993
- Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapyBlood, 1992
- Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantationBlood, 1992
- Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemiaBlood, 1992
- Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemiaBlood, 1991
- Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemiaBlood, 1989
- Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reactionBlood, 1988
- Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reactionBlood, 1988
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984